Neurocognitive screening in sickle cell disease
- PMID: 35716349
- DOI: 10.1002/pbc.29861
Neurocognitive screening in sickle cell disease
Comment on
-
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.Blood Adv. 2020 Apr 28;4(8):1554-1588. doi: 10.1182/bloodadvances.2019001142. Blood Adv. 2020. PMID: 32298430 Free PMC article.
References
REFERENCES
-
- DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016;127(7):829-838. doi:10.1182/blood-2015-09-618579
-
- Bernaudin F, Verlhac S, Arnaud C, et al. Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood. 2015;125(10):1653-1661. doi:10.1182/blood-2014-09-599852
-
- Jordan LC, Kassim AA, Donahue MJ, et al. Silent infarct is a risk factor for infarct recurrence in adults with sickle cell anemia. Neurology. 2018;91(8):e781-e784. doi:10.1212/WNL.0000000000006047
-
- Kassim AA, Pruthi S, Day M, et al. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood. 2016;127(16):2038-2040. doi:10.1182/blood-2016-01-694562
-
- DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119(20):4587-4596. doi:10.1182/blood-2011-02-272682
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical